X

SEC EDGAR - Form 4 insider activity

Xenon Pharmaceuticals Inc. $XENE

Tracked equity - 3 filings indexed by Nortis

Nortis signal thesis

Buying activity is leading recent insider flow.

2

OM buys - 90d

0

OM sells - 90d

1

Routine filings

0

Cluster filings

$1.12M

Largest trade

56/100

Avg signal score

Filing tape

Recent filings

Last 30d: 3
Option ExerciseRoutine 10/100
filed 2026-10-17
KPCFO

Kelly Thomas Patrick - Chief Financial Officer

Option exercises are often compensation mechanics rather than a direct market view; what happens to the shares next matters more.

View source filing
Open-market BuyHigh signal 76/100
filed 2026-10-01
KPCFO

Kelly Thomas Patrick - Chief Financial Officer - $559.7K

Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.

View source filing
Open-market BuyHigh signal 82/100
filed 2026-10-01
MICEO

MORTIMER IAN - Director, PRESIDENT & CEO - $1.12M

Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.

View source filing